With a feud raging over what鈥檚 deemed a regulated 鈥渋ntoxicant,鈥 billions of cannabis dollars keep circling the drain.
Forming America's sixth largest crop yielding 48.8 million pounds of flower and projected to generate $33.5 billion in 2023 legal sales, cannabis鈥 plunging price-per-pound and the availability of cheaper, unregulated hemp-derived tetrahydrocannabinol (THC) products is thwarting the cannabis industry.
Whether cultivated indoors, outdoors or in a greenhouse, over the past two-and-a-half years cannabis wholesale price-per-pound has dropped 40% nationally, curtailing production and crashing businesses across the legalized cannabis supply chain.聽
Further, mirroring legalized cannabis THC鈥檚 (delta-9-THC) effects, hemp-derived THC (delta-8-THC) requires no license, is readily available online and over-the-counter, and is cutting into legalized cannabis鈥 revenue despite growing state illegality, confusion over federal legality, and concerns regarding these untested and unregulated products鈥 safety and potency.聽
Cannabis and delta-9-THC
Cannabis can be grown in the ground, water (i.e., hydroponically), or pots outdoors, indoors or in a 鈥済reenhouse,鈥 a structure made of transparent material enabling natural sunlight and fresh air cultivation. Whether deemed 鈥渕edical鈥 (purchasable only with state-issued card to treat residents鈥 statutorily defined 鈥渃overed medical condition鈥) or 鈥渁dult-use鈥 (purchasable by anyone over 21 from any state with a valid identification), cannabis takes four forms:
Flower that is smoked
Oils ingested by vaporizing
Concentrates consumable after being heated to a high temperature
Infused products ranging from eye drops to edibles 聽
Those cultivating, processing, infusing, transporting or dispensing cannabis are deemed to be 鈥減lant-touching鈥 marijuana-related businesses (MRBs), and despite being legal in 38 American states, cannabis remains federally illegal. 聽聽
The Controlled Substance Act,聽21 U.S.C. 搂搂 801, Et. Seq (1970)聽(CSA) currently lists marijuana next to heroin as a Schedule I controlled substance having 鈥渁 high potential for abuse鈥 and for which there鈥檚 鈥渘o currently accepted medical use in treatment鈥 and 鈥渁 lack of accepted safety for use鈥 鈥渦nder medical supervision鈥.聽21 U.S.C. 搂812(b)(1).聽The CSA prohibits marijuana鈥檚 cultivation, distribution, dispensation and possession, and pursuant to the U.S. Constitution鈥檚 Supremacy Clause, state laws conflicting with federal law are generally preempted and void.聽U.S. Const., Art. VI, cl. 2; Wickard v. Filburn, 317 U.S. 111, 124 (1942)(鈥漑N]o form of state activity can constitutionally thwart the regulatory power granted by the commerce clause to Congress鈥). 聽
Because the CSA prevents cannabis from being sold outside of each respective legalized-marijuana state, and thus no 鈥渋nterstate cannabis commerce鈥 can occur, state regulators like California鈥檚 Department of Cannabis Control, and not federal agencies like the Food and Drug Administration, issue licenses and regulate MRBs.
Impact of cannabis' plunging price-per-pound
According to spot-market-index tracker Cannabis Benchmarks, cannabis鈥 wholesale price-per-pound has dropped 40% over the past two half years from $1,658 a pound to $955, with pricing currently at $1,284 a pound for indoor-grown flower, $688 a pound for greenhouse-cultivated cannabis, and $424 a pound for outdoor-grown cannabis.
Specifically, over the past year, Colorado鈥檚 average wholesale price dropped from $1,316 to is $658 per-pound; California鈥檚 price dropped 57% to $660 per-pound; Oregon鈥檚 volume-weighted average price dropped 39% to average $700 per-pound; and Oklahoma鈥檚 overall volume-weighted flower price is down 42% to $921 per-pound. 聽
According to聽Green Market Report, over the past year, Colorado鈥檚 medical and adult-use cannabis sales are down, respectively, 47% and 20%. Cannabis Benchmarks reports that, due to the price-per-pound depression, California is enduring production cutbacks ranging from 30% to not harvesting, resulting in a 24% (or over 40,000 pounds) shrinkage of wholesale flower entering California鈥檚 commercial market per quarter.
Because an MRB鈥檚 entire business model hinges on receiving a set price-per-pound, plummeting wholesale prices are causing havoc across the entire cannabis supply chain. For example, envision a recently licensed grower building its operation and raising funds using 2019 price-per-pound market price as the foundation for its projections to construct a $23 million indoor grow facility. Regardless of its markup, when the per-pound wholesale price drops 39%-57%, a grower鈥檚 ability to sell its product, subsidize its operations, service its debt, remunerate its investors and raise additional capital is severely impaired. 聽
The loss and reduced production gets passed along the cannabis supply chain, ranging from cannabis giant Canopy Growth slashing its workforce by 60% this year to nationwide multi-state grower, processor and dispensary Curaleaf laying off more than 100 employees in 2023.
Hemp and delta-8-THC
A fast-growing, sustainable and inexpensively produced plant, hemp is a variety of聽Cannabis sativa L.聽containing less than 0.3% plant chemical delta-9-THC.聽Agricultural Act of 2014, 7 U.S. Code 搂5940.聽Hemp yields more than 25,000 oil and fibrous products, including cannabidol (CBD), which offers broad health and wellness uses, serves as a food additive and is contained in many beauty items. 聽
The Agriculture Improvement Act of 2018 (2018 Farm Bill) both legalized hemp and its derivatives and removed plant聽Cannabis sativa L.聽containing no more than 0.3% delta-9-THC on a dry-weight basis from the CSA and Drug Enforcement Administration's (DEA) purview.聽7 U.S.C. 搂1639o(1).聽The Farm Bill permits importing, exporting and transporting hemp and hemp-derived products like any other crop; tasks the United States Department of Agriculture (USDA) with promulgating hemp regulations; and charges states, territories and Indian tribes with submitting hemp-growing regulation plans to the USDA including "THC testing procedures.鈥澛Id.
A cannabinoid of the THC family of compounds commonly derived from the cannabis plant, delta-8-THC is a double bond isomer of delta-9-THC, the federally illegal psychotropic-effect-producing cannabinoid sourced from cannabis. An isomer is a type of chemical analog comprising one of two or more compounds containing the identical number of atoms of the same elements but differing in structural arrangement and properties. There are 30 known THC isomers, and delta-9-THC and delta-8-THC differ regarding the single double bond鈥檚 location. 聽Stated another way, while similar in molecular structure, delta-8-THC is a different molecule than delta-9-THC.
Delta-8-THC is derived either directly from the hemp plant or converted from the CBD isolate. Because hemp cultivars do not express delta-8-THC in sufficient concentrations or quantities to be economically viable to extract for commercial purposes, and CBD is cheap and abundant, deriving delta-8-THC by converting from CBD isolate is the faster, cheaper and more popular method. 聽
Because they are less regulated, cheaper and, unlike delta-9-THC, can be sold virtually anywhere (including online) and as consumables, delta-8-THC smokable flower, vape and edibles sales are exploding and severely cutting into the legalized cannabis market.
Research firm Whitney Economics reports 2022 hemp product sales in excess of $28 billion and 聽that the hemp industry employs 328,000 workers earning $13 billion in wages.聽
Delta-8-THC's murky legality
Presently legal in the majority of the states, delta-8-THC products鈥 federal legality appears to hinge on whether derived directly from hemp or converted from CBD. 聽
At the state level, delta-8-THC products are as follows:
尝别驳补濒:听Alabama, Arkansas, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Maine, Maryland. Massachusetts, Mississippi, Missouri, Nebraska, New Hampshire, New Jersey, New Mexico, Ohio, Oklahoma (explicitly excludes delta-8 from marijuana鈥檚 legal definition), Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Washington D.C., West Virginia, Wisconsin and Wyoming
Illegal:聽Alaska, Colorado, Delaware, Idaho, Iowa, Montana, Nevada, New York, North Carolina, North Dakota, Oregon, Utah, Vermont and Washington
Legal but restricted or regulated:
Arizona
California (products with more than 0.3% delta-8-THC are state regulated)
Connecticut (only purchasable from a licensed cannabis retailer)
Hawaii (except for edible/inhalable products, delta-8-THC is legal)
Louisiana (while barring inhalables like flower and vapes, consumable delta-8 products like tinctures and gummies up to 8 mg THC per serving allowed)
Michigan (only purchasable from licensed cannabis retailer)
Minnesota (delta-8 plants may contain up to 0.3% of any THC type and consumables up to 5 mg THC per serving allowed)
聽Rhode Island
Virginia (except for food/drink THC-containing product)
Whether delta-8-THC is federally legal depends on whether derived directly from hemp or converted from CBD. Because the 2018 Farm Bill鈥檚 鈥渉emp鈥 definition encompasses 鈥渃annabinoids鈥 and 鈥渄erivatives鈥 of hemp, hemp-derived delta-8-THC is probably not prohibited by the CSA and delta-8-THC derived from CBD is probably also exempt (if not containing delta-9-THC concentrations exceeding 鈥0.3% by dry weight鈥 legal limit).聽
First, because the Farm Bill鈥檚 hemp definition distinguishes it from illegal marijuana, hemp falls outside of the CSA, which, in turn, excludes 鈥渉emp, as defined in section 1639o of title 7鈥, from its 鈥渕arihuana鈥 definition.聽7 U.S.C. 搂鈥1639o(1); 21 USC 搂802(16)(B).聽Further, because under the Farm Bill hemp-derived 鈥渃annabinoids鈥, 鈥渄erivatives鈥, 鈥渆xtracts鈥, and 鈥渋somers鈥 are themselves 鈥渉emp,鈥 delta-8-THC comprises Farm Bill defined hemp beyond the CSA鈥檚 scope.聽滨诲.听
Second, while clear that delta-8-THC naturally expressed in the hemp plant is not a controlled substance, the legal status of delta-8-THC derived from CBD or other hemp-derived cannabinoid requires satisfying the Farm Bill鈥檚 broad 鈥渉emp derivative鈥 definition. Stated another way, is a derivative of a derivative included in the Farm Bill鈥檚 hemp definition or is it a 鈥渟ynthetic鈥 falling out of this CSA safe harbor?
A division of federal authority exists. The 鈥淪ource Rule鈥 (i.e., that the source of a cannabinoid determines its legal status) suggest the former. Conversely, the DEA鈥檚 internal "Scheduling Actions, Controlled Substances, Regulated Chemicals" document, the "Orange Book", flatly lists 鈥淒elta-8 THC鈥 as a 鈥淪chedule 1 Tetrahydrocannabinol鈥 without any distinction as to 鈥渟ource鈥.聽
However, under the 鈥淟ex Specialis Doctrine鈥 (i.e., that when two federal laws appear in conflict on an issue, and one is older and more general than the other, the more recent and specific law controls), the more recent and specific Farm Bill would take precedence over the older and more generalized CSA, encompass delta-8 hemp in its hemp definition, and remove it from the DEA鈥檚 purview. In聽Re Lazarus, 478 F.3d 12 (1st Cir. 聽January 9, 2007).
With the 2018 Farm Bill 鈥渆xtended鈥 until Sept. 30, 2024 by the recently signed 鈥淔urther Continuing Appropriations and Other Extensions Act鈥, until Congress, the DEA or the USDA take action, delta-8-THC鈥檚 federal legality remains unclear and proceeding hinges on the following.
First, is the delta-8-THC derived from cannabis (i.e., containing delta-9-THC concentrations exceeding 鈥0.3% by dry weight鈥 legal limit) or hemp? Producing or selling delta-8 products without a permit to produce or sell THC violates the CSA and risks criminal and civil sanctions from the DEA, USDA, Federal Trade Commission and state law enforcement and regulators.
Second, if not cannabis-sourced, is delta-8-THC derived directly from hemp or CBD, and what is the seller鈥檚 risk tolerance? While seemingly fairly settled that hemp-derived delta-8-THC falls outside of the CSA, questions remain whether CBD-derived delta-8-THC is allowable under the Farm Bill or impermissible as a 鈥渟ynthetic鈥. Further, unlike fly-by-night sellers, licensed cannabis and hemp growers, processers and sellers are subject to, and face the wrath of, their respective regulators. 聽
Third, in the state that the online or over-the-counter purchase and sale is occurring, has that state prohibited delta-8 THC, and how robust are these respective enforcement efforts?
Fourth, even if not illegal, what risk management concerns exist and what tools are available to manage them? Tremendous safety, potency, torts risks and exposure are imposed by selling an untested products in an unregulated market for which neither product certification nor insurance coverage is available.聽